To evaluate the relationship between the expression of UGT2B17 and ZAP70, we initially studied the GSE21029 data set that provides gene expression from purified tumor cells obtained concurrently from blood, bone marrow, and lymph nodes of CLL patients. The gene discussed is UGT2B17; the disease is neoplasm.